ResMed Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 53 trades in ResMed Inc (NYSE: RMD) since 2013, across 9 members, worth an estimated $1.2M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 29 buys against 24 sells, a modestly buy-led skew, with Democratic members responsible for 83% of the trades and Republican members 17%. The most recent disclosure shown was filed July 2026, and Rohit Khanna has filed the most RMD transactions among those shown, with 12. One notable disclosed move was a purchase by Rohit Khanna on January 29, 2026, down 24.7% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the ResMed Inc (RMD) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
ResMed congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Rohit Khanna House | Jul 6, 2026 | Jun 30, 2026 | 6 days | SELL |  $1,001 - $15,000 | -0.96% | Spouse | |
Rohit Khanna House | Jul 6, 2026 | Jun 16, 2026 | 20 days | BUY | $1,001 - $15,000 | -0.48% | Spouse | |
Rohit Khanna House | Jun 9, 2026 | May 27, 2026 | 13 days | BUY | $1,001 - $15,000 | -6.35% | Spouse | |
Rohit Khanna House | Jun 9, 2026 | May 15, 2026 | 25 days | SELL | $1,001 - $15,000 | -4.39% | Spouse | |
Rohit Khanna House | Jun 9, 2026 | May 1, 2026 | 39 days | BUY | $1,001 - $15,000 | -5.58% | Dependent Child | |
Rohit Khanna House | May 11, 2026 | Apr 24, 2026 | 17 days | BUY | $1,001 - $15,000 | -11.95% | Spouse | |
Rohit Khanna House | May 11, 2026 | Apr 13, 2026 | 28 days | BUY | $1,001 - $15,000 | -15.93% | Spouse | |
Rohit Khanna House | Apr 7, 2026 | Mar 30, 2026 | 8 days | SELL | $1,001 - $15,000 | -12.02% | Dependent Child | |
Rohit Khanna House | Apr 7, 2026 | Mar 23, 2026 | 15 days | SELL | $1,001 - $15,000 | -15.08% | Spouse | |
Rohit Khanna House | Mar 9, 2026 | Feb 24, 2026 | 13 days | BUY | $1,001 - $15,000 | -23.07% | Dependent Child |
ResMed (RMD) congressional trading FAQ
Can members of Congress legally trade ResMed (RMD) stock?
Yes. Members of Congress are permitted to trade individual stocks, including ResMed (RMD), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional ResMed (RMD) trades public?
Yes. Every congressional trade in ResMed (RMD) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded ResMed (RMD)?
Members of Congress have disclosed 53 trades in ResMed (RMD) worth $1.2M across 9 members, according to public STOCK Act filings.
Which members of Congress have traded ResMed (RMD)?
Recent and active filers of ResMed (RMD) disclosures include Rohit Khanna. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade ResMed (RMD) more?
Across disclosed ResMed (RMD) trades, 83% were by Democrats and 17% by Republicans, led by Democrats (83%).
What is the most recent congressional ResMed (RMD) trade?
The most recent disclosed ResMed (RMD) trade was a purchase by Rohit Khanna, filed Jul 5, 2026.
Browse all stocks Congress tradesCongressional trading overviewResMed (RMD) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.